Ethics Panel: ‘Substantial Reason To Believe’ Collins Broke Federal Law

By   – There is “a substantial reason to believe” that Rep. Chris Collins violated federal law by touting the stock of an obscure Australian biotech firm based on inside information, while also possibly breaking House ethics rules by persuading National Institutes of Health officials to meet with a staffer from that company.

Those were the key conclusions of an Office of Congressional Ethics report released Thursday on Collins’ relationship with an Australian biotech firm called Innate Immunotherapeutics. Based on that report, the House Ethics Committee said it was continuing its investigation of Collins, a Republican from Clarence and one of President Trump’s strongest congressional allies.

The Office of Congressional Ethics recommended that the committee dismiss a third charge against Collins: that he got a discount on Innate’s stock based on the fact that he was a member of Congress.

But the two remaining charges against Collins and the 155 pages of evidence released with the Office of Congressional Ethics report collectively portray a congressman working hard on behalf of an Australian company in possible violation of U.S. law and House ethics rules.
Read more…

Comments are closed.